Suppression of α smooth muscle actin expression by IFN-γ in established myofibroblast cell lines

Journal of Interferon and Cytokine Research

Volumn 27, Issue 10, 2007, Pages 835-839

  Tanaka, Kazunari ^a   Sano, Kouichi ^a   Nakano, Takashi ^a   Yuba, Kazuhide ^a   Kinoshita, Mitsuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GAMMA INTERFERON;

ARTICLE; CELL COUNT; CELL CULTURE; CELL DENSITY; CELL LINE; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN NODULE;

ACTINS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MUSCLE, SMOOTH; RNA, MESSENGER;

BOVINAE;

EID: 35648937096     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0028     Document Type: Article

References (24)

1. Tomasek JJ, Vaughan MB, Haaksma CJ. Cellular structure and biology of Dupuytren's disease. Hand Clin. 1992;15:21-33.
2. Foo IT, Naylor IL, Timmons MJ, Trejdosiewicz LK. Intracellular actin as a marker for myofibroblasts in vitro. Lab. Invest. 1992;67:727-733.
3. Tomasek J, Rayan GM. Correlation of α-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts. J. Hand Surg. Am. Vol. 1995;20:450-455.
4. Mounier N, Desmoulière A, Gabbiani G. Subcutaneous tissue fibroblasts transfected with muscle and nonmuscle actins: a good in vitro model to study fibroblastic cell plasticity. Wound Repair Regen. 1999;7:45-52.
5. R nnv-Jessen L, Peterson W. A function for filamentous α-smooth muscle actin: retardation of motility in fibroblasts. J. Cell Biol. 1996;134:67-80.
6. Pittet B, Rubbia BL, Desmouliere A, Sappino AP, Roggero P, Guerret S, Grimaud JA, Lacher R, Montandon D, Gabbiani G. Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast. Reconstr. Surg. 1994;93:1224-1235.
7. Sanders JL, Dodd C, Ghahary A, Scott PG, Tredget EE. The effect of interferon-α2b on an in vitro model Dupuytren's contracture. J. Hand Surg. Am. Vol. 1999;24:578-585.
8. Tanaka K, Sano K, Tanaka K, Kobayashi M, Katsumura K, Ikeda T, Abe M. Demonstration of downregulation of α-smooth muscle actin (αSMA) in interferon γ-treated myofibroblast by a novel cell-capture enzyme immunoassay. Int. Immunopharmacol. 2001;1:769-775.
9. Tanaka K, Sano K, Yuba K, Katsumura K, Nakano T, Tanaka K, Kobayashi M, Ikeda T, Abe M. Inhibition of induction of myofibroblasts by interferon γ in a human fibroblast cell line. Int. Immunopharmacol. 2003;3:1273-1280.
10. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993;122:103-111.
11. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor-β in Dupuytren's disease. J. Hand Surg. Am. Vol. 1996;21:210-215.
12. Hindman HB, Marty-Roix R, Tang JB, Jupiter JB, Simmons BP, Spector M. Regulation of expression of α-smooth muscle actin in cells of Dupuytren's contracture. J. Bone Joint Surg. Br. Vol. 2003;85:448-455.
13. Yuba K, Sano K, Nakano T, Mori H, Tanaka K, Tanaka K, Daikoku E, Okada Y, Kinosita M, Abe M. Frequent establishment of long-term-cultured myofibroblast cell lines derived from Dupuytren's nodules, which are implantable into nude mice. Bull. Osaka Med. Coll. 2007;53:123-132.
14. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 1986;103:2787-2797.
15. Kobayashi M, Sano K, Katsumura K, Tanaka K, Sugiyama T, Doi S, Abe M, Ikeda T. Determination of optimal conditions for the immobilization of cells in a cell capture enzyme immunoassay (CC-EIA) by a simple Giemsa assay. J. Immunoassay 2000;21:297-314.
16. Reddy S, Ozgur K, Lu M, Chang W, Mohan SR, Kumar CC, Ruley HE. Structure of the human smooth muscle α-actin gene. Analysis of cDNA and 5′ upstream region. J. Biol. Chem. 1990;265:1683-1687.
17. Luck JV. Dupuytren's contracture: a new concept of the pathogenesis correlated with surgical management. J. Bone Joint Surg. Am. Vol. 1959;41:635-664.
18. Schürch W, Skalli O, Gabbiani G. Cellular biology. In: McFarlane RM, McGrouther DA, Flint MH, eds. Dupuytren's Disease: Biology and Treatment. London: Churchill Livingstone, 1990:31-47.
19. Serini G, Gabbiani G. Mechanism of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 1999;250:273-283.
20. Magro G, Lanterni E, Micali G, Paravizzini G, Travali S, Lanzafame S. Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor. J. Pathol. 1997;181:213-217.
21. Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ. Transforming growth factor-β: possible roles in Dupuytren's contracture. J. Hand Surg. Am. Vol. 1995;20:101-108.
22. Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of α-smooth muscle actin and the response to stimulation by TGF-β1. J. Hand Surg. Br. Eur. Vol. 2003;28:351-356.
23. Baird KS, Crossan JF, Ralston SH. Abnormal growth factor and cytokine expression in Dupuytren's contracture. J. Clin. Pathol. 1993;46:425-428.
24. Holly RW. Control of growth of mammalian cells in cell culture. Nature 1975;258:487-490.